BRIEF-Fitch says FDA biosimilar label guidance supportive for growth
 

BRIEF-Fitch says FDA biosimilar label guidance supportive for growth
* Believe biosimilar market could eventually evolve to a point where it operates like traditional small-molecule generic drug markethttp://feeds.feedburner.com/~ff/reut...?d=yIl2AUoC8zA http://feeds.feedburner.com/~ff/reut...hw:F7zBnMyn0Lo http://feeds.feedburner.com/~ff/reut...hw:V_sGLiPBpWU
http://feeds.feedburner.com/~r/reute...~4/0sAOBLHQVsc